|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Search with the first character of the name of the medicinal product: t
| Summaries of Product Characteristics 1 - 30 of 357 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
|
|
European Medicines Agency's website:
Tabrecta - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Tacforius - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
TachoSil - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Tacrolimus Accord 0,03 % voide SPC 2022-12-29
|
|
PL
|
Resepti
|
Tacrolimus Accord 0,1 prosenttia voide SPC 2022-12-29
|
|
PL
|
Resepti
|
Tadalafil Accord 10 mg kalvopäällysteiset tabletit SPC 2024-03-11
|
|
PL
|
Resepti
|
Tadalafil Accord 2,5 mg kalvopäällysteiset tabletit SPC 2024-03-11
|
|
PL
|
Resepti
|
Tadalafil Accord 20 mg kalvopäällysteiset tabletit SPC 2024-03-13
|
|
PL
|
Resepti
|
Tadalafil Accord 5 mg kalvopäällysteiset tabletit SPC 2024-03-11
|
|
PL
|
Resepti
|
Tadalafil AOP 20 mg tabletti, kalvopäällysteinen, SPC 2024-01-02
|
|
PL
|
Resepti
|
Tadalafil Krka 10 mg tabletti, kalvopäällysteisnen SPC 2022-03-02
|
|
PL
|
Resepti
|
Tadalafil Krka 2.5 mg tabletti, kalvopäällysteinen SPC 2022-03-02
|
|
PL
|
Resepti
|
Tadalafil Krka 20 mg tabletti, kalvopäällysteinen SPC 2022-03-02
|
|
PL
|
Resepti
|
Tadalafil Krka 5 mg tabletti, kalvopäällysteisnen SPC 2022-03-02
|
|
|
|
European Medicines Agency's website:
Tadalafil Lilly - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Tadalafil Mylan - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Tadalafil Orion 10 mg tabletti, kalvopäällysteinen SPC 2023-10-26
|
|
PL
|
Resepti
|
Tadalafil Orion 20 mg tabletti, kalvopäällysteinen SPC 2023-10-26
|
|
PL
|
Resepti
|
Tadalafil Orion 5 mg tabletti, kalvopäällysteinen SPC 2023-10-26
|
|
PL
|
Resepti
|
Tadalafil ratiopharm 10 mg tabletti, kalvopäällysteinen SPC 2024-01-16
|
|
PL
|
Resepti
|
Tadalafil ratiopharm 20 mg tabletti, kalvopäällysteinen SPC 2024-01-16
|
|
PL
|
Resepti
|
Tadalafil ratiopharm 5 mg tabletti, kalvopäällysteinen SPC 2024-01-16
|
|
PL
|
Resepti
|
Tadalafil Sandoz, 5 mg, 10 mg ja 20 mg tabletti, kalvopäällysteinen SPC 2023-10-17
|
|
PL
|
Resepti
|
Tadalafil Stada 10 mg tabletti, kalvopäällysteinen SPC 2023-09-18
|
|
PL
|
Resepti
|
Tadalafil Stada 20 mg tabletti, kalvopäällysteinen SPC 2023-09-18
|
|
PL
|
Resepti
|
Tadalafil Stada 5 mg tabletti, kalvopäällysteinen SPC 2023-09-18
|
|
PL
|
Resepti
|
Tadalafil STADA Nordic 10 mg tabletti, kalvopäällysteinen SPC 2023-09-19
|
|
PL
|
Resepti
|
Tadalafil STADA Nordic 20 mg tabletti, kalvopäällysteinen SPC 2023-09-19
|
|
PL
|
Resepti
|
Tadalafil STADA Nordic 5 mg tabletti, kalvopäällysteinen SPC 2023-09-19
|
|
PL
|
Resepti
|
Tadex 20 mg tabletti SPC 2023-11-27
|
|
|
| |
